Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with γ-irradiation and cisplatin treatment in vivo

British Journal of Radiology

Volumn 82, Issue 977, 2009, Pages 392-400

  Masunaga, Shin Ichiro ^a   Tano, K ^b   Watanabe, M ^b   Kashino, G ^a   Suzuki, M ^a   Kinashi, Y ^b   Ono, K ^a   Nakamura, J ^c  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CISPLATIN; METHENAMINE; TIRAPAZAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOTOXICITY; GAMMA IRRADIATION; IMMUNOFLUORESCENCE; LD 50; MOUSE; NONHUMAN; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; GAMMA RAYS; INFUSIONS, SUBCUTANEOUS; METHENAMINE; MICE; MICE, INBRED C3H; RADIATION-SENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME; TRIAZINES; TUMOR CELLS, CULTURED;

EID: 65749116479     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/54190057     Document Type: Article

References (18)

1. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-648
2. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-549
3. Lin AJ, Cosby LA, Shansky CW, Sartorelli AC. Potential bioreductive alkylating agents. 1. Benzoquinone derivatives. J Med Chem 1973;15:1247-1252
4. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004;4:437-447 (Pubitemid 38745529)
5. Masunaga S, Ono K. Significance of the response of quiescent cell populations within solid tumors in cancer therapy. J Radiat Res 2002;43:11-25. (Pubitemid 135693382)
6. Brown JM. Evidence of acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 1979;52:650-656 (Pubitemid 9239867)
7. Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, et al. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations. Int J Hyperthermia 2005;21:305-318
8. McKeown SR, Cowen RL, Williams KJ. Bioreductive drugs: from concept to clinic. Clin Oncol 2007;19:427-442 (Pubitemid 46995614)
9. Adam M, Bayer C, Henke J, Grosu A, Molls M, Nieder C. Tirapazamine plus cisplatin and irradiation in a mouse model: improved tumor control at the cost of increased toxicity. J Cancer Res Clin Oncol 2008;134:137-146 (Pubitemid 350234057)
10. Ridpath JR, Nakamura J, Tano K, Luke AM, Sonoda E, Arakawa H, et al. Cells deficient in the Fanc/Brac pathway are hypersensitive to plasma levels of formaldehyde. Cancer Res 2007;67:11117-11122 (Pubitemid 350248534)
11. Swift LP, Cutts SM, Rephaeli A, Nudelman A, Phillips DR. Activation of adriamycin by the pH-dependent formaldehyde-releasing prodrug hexamethylenetetramine. Mol Cancer Therapeut 2003;2:189-198
12. Masunaga S, Ono K, Suzuki M, Nishimura Y, Kinashi Y, Takagaki M, et al. Radiosensitization effect by combination with paclitaxel in vivo including the effect on intratumor quiescent cells. Int J Radiat Oncol Biol Phys 2001;50:1063-1072
13. Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Kinashi Y, et al. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low temperature hyperthermia. Radiat Med 1998;16:441-448
14. Hubal EA, Schlosser PM, Conolly RB, Kimbell JS. Comparison of inhaled formaldehyde dosimetry predictions with DNA-protein cross-link measurements in the rat nasal passages. Toxicol Appl Pharmacol 1997;143:47-55. (Pubitemid 27130606)
15. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006;66:8927-8930 (Pubitemid 44521105)
16. Masunaga S, Ono K, Hori H, Shibata T, Suzuki M, Kinashi Y, et al. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, using the micronucleus assay. Jpn J Cancer Res 1997;88:907-914 (Pubitemid 27475094)
17. Hoogsteen IJ, Marres HA, van der Kogel AJ, Kaanders JH. The hypoxic microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol 2007;19:385-396 (Pubitemid 47007426)
18. Masunaga S, Ono K, Mitsumori M, Abe M. The alteration of radiosensitivity of quiescent cell populations in murine solid tumors irradiated twice at various intervals with xrays. Jpn J Cancer Res 1993;84:1130-1135 (Pubitemid 23351004)